The University of Maryland School of Medicine (UMSOM) has been awarded a $200 million grant by the National Institutes of Health for the Center for Vaccine Development and Global Health (CVD) .
This research contract is one of the largest ever awarded to UMSOM and includes approximately $2.5 million to begin conducting clinical testing of influenza vaccines.
CVD’s research is aimed at testing improved seasonal influenza vaccines and conducting controlled human influenza challenge studies for NIAID’s Collaborative Influenza Vaccine Innovation Center (CIVICs) program. The Center has the ultimate goal of developing a universal vaccine to protect against emerging influenza strains all across the world as well as improvements to current seasonal vaccines.
MPK&D works with UMSOM in board development and other projects.